- Home
- TASK vs PLSE Comparison
TASK vs PLSE Comparison
Compare TASK & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TASK
- PLSE
- Stock Information
- Founded
- TASK 2008
- PLSE 2014
- Country
- TASK United States
- PLSE United States
- Employees
- TASK N/A
- PLSE N/A
- Industry
- TASK Retail: Computer Software & Peripheral Equipment
- PLSE Medical/Dental Instruments
- Sector
- TASK Technology
- PLSE Health Care
- Exchange
- TASK Nasdaq
- PLSE Nasdaq
- Market Cap
- TASK 1.1B
- PLSE 1.0B
- IPO Year
- TASK 2021
- PLSE 2016
- Fundamental
- Price
- TASK $13.76
- PLSE $16.64
- Analyst Decision
- TASK Hold
- PLSE
- Analyst Count
- TASK 7
- PLSE 0
- Target Price
- TASK $16.71
- PLSE N/A
- AVG Volume (30 Days)
- TASK 278.5K
- PLSE 194.0K
- Earning Date
- TASK 11-07-2024
- PLSE 10-30-2024
- Dividend Yield
- TASK N/A
- PLSE N/A
- EPS Growth
- TASK 29.08
- PLSE N/A
- EPS
- TASK 0.58
- PLSE N/A
- Revenue
- TASK $955,007,000.00
- PLSE N/A
- Revenue This Year
- TASK $7.61
- PLSE N/A
- Revenue Next Year
- TASK $7.97
- PLSE N/A
- P/E Ratio
- TASK $23.57
- PLSE N/A
- Revenue Growth
- TASK 2.43
- PLSE N/A
- 52 Week Low
- TASK $10.56
- PLSE $5.97
- 52 Week High
- TASK $19.60
- PLSE $22.69
- Technical
- Relative Strength Index (RSI)
- TASK 50.38
- PLSE 46.49
- Support Level
- TASK $14.39
- PLSE $17.14
- Resistance Level
- TASK $19.60
- PLSE $20.14
- Average True Range (ATR)
- TASK 1.09
- PLSE 1.48
- MACD
- TASK 0.01
- PLSE -0.03
- Stochastic Oscillator
- TASK 23.96
- PLSE 42.43
About TASK TaskUs Inc.
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to inventive and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.